Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) — Net Asset Quality Index
Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a Net Asset Quality Index of 72.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.21 Billion minus total liabilities of CN¥1.43 Billion yields net assets of CN¥3.78 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 300233 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Net Asset Quality Index Over Time (2008–2025)
This chart shows how Shandong Jincheng Pharmaceutical and Chemical Co Ltd's Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of March 2026, the index stands at 72.6%, representing net assets of CN¥3.78 Billion against total assets of CN¥5.21 Billion CNY. See Shandong Jincheng Pharmaceutical and Che (300233) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
The table below presents the year-by-year Net Asset Quality Index for Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 300233 market cap overview.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 71.7% | CN¥3.72 Billion | CN¥5.19 Billion | CN¥1.47 Billion | ▲ +3.4 pp |
| 2024 | 68.4% | CN¥3.83 Billion | CN¥5.60 Billion | CN¥1.77 Billion | ▲ +4.5 pp |
| 2023 | 63.9% | CN¥3.78 Billion | CN¥5.92 Billion | CN¥2.14 Billion | ▲ +1.1 pp |
| 2022 | 62.8% | CN¥3.66 Billion | CN¥5.83 Billion | CN¥2.17 Billion | ▼ -2.4 pp |
| 2021 | 65.2% | CN¥3.44 Billion | CN¥5.28 Billion | CN¥1.84 Billion | ▼ -4.1 pp |
| 2020 | 69.3% | CN¥3.47 Billion | CN¥5.00 Billion | CN¥1.53 Billion | ▼ -3.7 pp |
| 2019 | 73.0% | CN¥4.08 Billion | CN¥5.59 Billion | CN¥1.51 Billion | ▼ -4.3 pp |
| 2018 | 77.3% | CN¥4.09 Billion | CN¥5.29 Billion | CN¥1.20 Billion | ▼ -3.0 pp |
| 2017 | 80.3% | CN¥3.94 Billion | CN¥4.90 Billion | CN¥966.24 Million | ▲ +13.6 pp |
| 2016 | 66.6% | CN¥1.50 Billion | CN¥2.26 Billion | CN¥752.68 Million | ▲ +1.0 pp |
| 2015 | 65.6% | CN¥1.31 Billion | CN¥2.00 Billion | CN¥685.95 Million | ▲ +3.1 pp |
| 2014 | 62.5% | CN¥1.12 Billion | CN¥1.79 Billion | CN¥668.61 Million | ▼ -2.3 pp |
| 2013 | 64.8% | CN¥1.02 Billion | CN¥1.58 Billion | CN¥554.11 Million | ▼ -1.5 pp |
| 2012 | 66.4% | CN¥975.57 Million | CN¥1.47 Billion | CN¥494.26 Million | ▼ -2.2 pp |
| 2011 | 68.6% | CN¥958.84 Million | CN¥1.40 Billion | CN¥439.36 Million | ▲ +29.4 pp |
| 2010 | 39.2% | CN¥375.33 Million | CN¥957.95 Million | CN¥582.62 Million | ▼ -1.5 pp |
| 2009 | 40.6% | CN¥281.53 Million | CN¥692.56 Million | CN¥411.04 Million | ▲ +6.1 pp |
| 2008 | 34.6% | CN¥216.49 Million | CN¥626.16 Million | CN¥409.67 Million | — |